Literature DB >> 26920595

Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults.

Anat Berkovitch1, Shaye Kivity2, Robert Klempfner3, Shlomo Segev4, Assi Milwidsky5, Aharon Erez3, Avi Sabbag3, Ilan Goldenberg3, Yechezkel Sidi6, Elad Maor7.   

Abstract

BACKGROUND: Increased body mass index (BMI) and obesity are associated with increased risk of new-onset atrial fibrillation (AF) among middle-aged adults.
OBJECTIVES: The objective of the study is to investigate the association between BMI and the risk for new-onset AF among middle-aged adults.
METHODS: We investigated 18,290 men and women who were annually screened in a tertiary medical center. Participants were divided at baseline into 3 groups: normal weight (BMI ≥18 and <25 kg/m(2), n = 7,692), overweight (BMI ≥25 and <30 kg/m(2), n = 8,032), and obese (BMI ≥30 kg/m(2), n = 2,566). The primary end point was new-onset AF during follow-up.
RESULTS: Mean age of study population was 49 ± 11 years, and 73% were men. A total of 288 incident events (1.6%) occurred during 6 ± 4 years. Kaplan-Meier survival analysis showed that the cumulative probability of AF at 6 years was highest among obese participants, intermediate among overweight participants, and lowest among participants with normal weight (2.1%, 1.7%, and 0.8% respectively, P < .001). Multivariable Cox regression analysis showed that overweight and obesity were independently associated with increased AF risk (hazard ratio 1.54 [P = .004] and 2.41 [P < .001], respectively). Assessment of BMI change as a time-dependent covariate in the multivariable model showed that each 1 kg/m(2) reduction in BMI during follow-up was associated with a significant 7% reduction in the risk for the occurrence of a first AF event (hazard ratio 0.93, 95% CI 0.88-0.99, P = .019). Consistently, similar analysis showed that each 5-kg weight loss during follow-up was independently associated with a significant 12% reduced risk of new-onset AF (95% CI 0.81-0.98, P = .02).
CONCLUSIONS: Our findings suggest that overweight and obesity are associated with increased AF risk, whereas weight reduction is independently associated with reduced risk of de novo AF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26920595     DOI: 10.1016/j.ahj.2015.11.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  Association of serum adropin with the presence of atrial fibrillation and atrial remodeling.

Authors:  Bin Wang; Yusheng Xue; Fujun Shang; Sifeng Ni; Xiongtao Liu; Boyuan Fan; Haichang Wang
Journal:  J Clin Lab Anal       Date:  2018-09-21       Impact factor: 2.352

2.  The Effect of Positive Airway Pressure Treatment of Obstructive and Central Sleep Apnea on the Recurrence of Atrial Fibrillation/Flutter Postintervention.

Authors:  Narat Srivali; Anwar C Chahal; Meghna P Mansukhani; Jay Mandrekar; Virend K Somers; Sean M Caples
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

3.  Height, Weight, and Aerobic Fitness Level in Relation to the Risk of Atrial Fibrillation.

Authors:  Casey Crump; Jan Sundquist; Marilyn A Winkleby; Kristina Sundquist
Journal:  Am J Epidemiol       Date:  2018-03-01       Impact factor: 4.897

4.  The Influence of Obesity on the Association of Obstructive Sleep Apnea and Atrial Fibrillation.

Authors:  Patrick L Stafford; Evan K Harmon; Paras Patel; McCall Walker; Gen-Min Lin; Seung-Jung Park; Neal A Chatterjee; Nishaki K Mehta; Sula Mazimba; Kenneth Bilchick; Younghoon Kwon
Journal:  Sleep Med Res       Date:  2021-06-24

Review 5.  Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies.

Authors:  Dagfinn Aune; Abhijit Sen; Sabrina Schlesinger; Teresa Norat; Imre Janszky; Pål Romundstad; Serena Tonstad; Elio Riboli; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2017-02-13       Impact factor: 8.082

6.  Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population-Based Tromsø Study.

Authors:  Jocasta Ball; Maja-Lisa Løchen; Tom Wilsgaard; Henrik Schirmer; Laila A Hopstock; Bente Morseth; Ellisiv B Mathiesen; Inger Njølstad; Sweta Tiwari; Ekaterina Sharashova
Journal:  J Am Heart Assoc       Date:  2018-04-19       Impact factor: 5.501

7.  Refining the Association Between Body Mass Index and Atrial Fibrillation: G-Formula and Restricted Mean Survival Times.

Authors:  Sarah C Conner; Sara Lodi; Kathryn L Lunetta; Juan P Casas; Steven A Lubitz; Patrick T Ellinor; Christopher D Anderson; Qiuxi Huang; Justin Coleman; Wendy B White; Emelia J Benjamin; Ludovic Trinquart
Journal:  J Am Heart Assoc       Date:  2019-08-08       Impact factor: 5.501

8.  Incidence and Predictors of Atrial Fibrillation Progression.

Authors:  Steffen Blum; Stefanie Aeschbacher; Pascal Meyre; Leon Zwimpfer; Tobias Reichlin; Jürg H Beer; Peter Ammann; Angelo Auricchio; Richard Kobza; Paul Erne; Giorgio Moschovitis; Marcello Di Valentino; Dipen Shah; Jürg Schläpfer; Selina Henz; Christine Meyer-Zürn; Laurent Roten; Matthias Schwenkglenks; Christian Sticherling; Michael Kühne; Stefan Osswald; David Conen
Journal:  J Am Heart Assoc       Date:  2019-10-08       Impact factor: 5.501

9.  Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis.

Authors:  Nicholas R Jones; Kathryn S Taylor; Clare J Taylor; Paul Aveyard
Journal:  Heart       Date:  2019-06-22       Impact factor: 5.994

10.  Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US).

Authors:  Jeffrey S Berger; François Laliberté; Akshay Kharat; Dominique Lejeune; Kenneth Todd Moore; Young Jung; Patrick Lefebvre; Veronica Ashton
Journal:  Adv Ther       Date:  2021-05-25       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.